Journal article
The Low Prevalence and High Cost of Routine Antiphospholipid Antibody Testing in Patients with Recurrent Pregnancy Loss
Fertility and sterility, Vol.119(6), pp.1078-1080
06/2023
DOI: 10.1016/j.fertnstert.2023.03.026
PMID: 36972747
Abstract
Objective
Testing for antiphospholipid antibodies (aPLs) is recommended and widely practiced for patients with recurrent pregnancy loss (RPL) based, in part, on a reported prevalence of antiphospholipid syndrome ranging from 8%–42% in patients experiencing multiple miscarriages (1). However, this prevalence may be inflated because these studies were performed before the implementation of new standardized guidelines for aPLs testing. Our primary objective was to evaluate the rate of confirmed aPL positivity in patients with RPL as currently defined by the American Society for Reproductive Medicine practice guidelines and according to the international recommendations for proper laboratory testing. Secondary objectives were to determine the costs associated with aPL testing and the clinical factors associated with aPL positivity among patients with RPL. The University of Iowa Institutional Review Board reviewed and approved the methods for this study (IRB# 202112378).
Details
- Title: Subtitle
- The Low Prevalence and High Cost of Routine Antiphospholipid Antibody Testing in Patients with Recurrent Pregnancy Loss
- Creators
- Renee G Cafun - University of Iowa Carver College of MedicineAnna Merrill - Department of Pathology, University of Iowa Carver College of Medicine, Iowa City, IowaSharathkumar M Bhagavathi - Department of Pathology, University of Iowa Carver College of Medicine, Iowa City, IowaKaren M Summers - University of IowaBrittany A Bettendorf - University of IowaBradley J Van Voorhis - Department of Obstetrics and Gynecology, University of Iowa Carver College of Medicine, Iowa City, Iowa. Electronic address: brad-van-voorhis@uiowa.edu
- Resource Type
- Journal article
- Publication Details
- Fertility and sterility, Vol.119(6), pp.1078-1080
- DOI
- 10.1016/j.fertnstert.2023.03.026
- PMID
- 36972747
- NLM abbreviation
- Fertil Steril
- ISSN
- 0015-0282
- eISSN
- 1556-5653
- Language
- English
- Electronic publication date
- 03/25/2023
- Date published
- 06/2023
- Academic Unit
- Pathology; Obstetrics and Gynecology; Injury Prevention Research Center; Immunology; Internal Medicine
- Record Identifier
- 9984381134802771
Metrics
17 Record Views